title: 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis.
abstract: 4-Hydroxynonenal (HNE) is by far the most investigated aldehydic end-product of oxidative breakdown of membrane n-6 polyunsaturated fatty acids. Its potential involvement in the pathogenesis of atherosclerosis has been corroborated by its consistent detection in both oxidized LDL and fibrotic plaque in humans. HNE has been shown to activate both macrophage and smooth muscle cells, i.e. the two key cell types in chronic inflammatory processes characterized by excessive fibrogenesis. By signalling to the nucleus, the aldehyde may up-regulate in these cells both expression and synthesis of monocyte chemotactic protein 1 (MCP-1) and transforming growth factor beta1 (TGFbeta1). Oxysterols, namely 27 carbon atoms oxidation products of cholesterol, are found in relatively high amount in LDL from hypercholesterolemic individuals and are consistently detectable in foam cells and necrotic core of human atherosclerotic lesion. As for HNE, the challenge of cells of the macrophage lineage with a mixture of oxysterols like that detectable in hypercholesterolemic individuals led to a marked overexpression of TGFbeta1 and MCP-1. Both HNE and oxysterols then appear to be candidates for a primary role in the progression of the atherosclerotic process.
authors.affiliation: Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
authors.forename: Gabriella
authors.initials: G
authors.lastname: Leonarduzzi
authors.forename: Elena
authors.initials: E
authors.lastname: Chiarpotto
authors.forename: Fiorella
authors.initials: F
authors.lastname: Biasi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Poli
mesh_terms: D000447:Aldehydes / Q000032:analysis / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D050197:Atherosclerosis / Q000378:metabolism*; D002467:Cell Nucleus / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism*; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D007249:Inflammation; D008077:Lipoproteins, LDL / Q000737:chemistry; D008262:Macrophage Activation / Q000187:drug effects; D015394:Molecular Structure; D032389:Myocytes, Smooth Muscle / Q000187:drug effects / Q000502:physiology; D010084:Oxidation-Reduction; D015398:Signal Transduction; D013261:Sterols / Q000737:chemistry / Q000494:pharmacology; D014157:Transcription Factors / Q000502:physiology
chemical_list: D000447:Aldehydes; D008077:Lipoproteins, LDL; D013261:Sterols; D014157:Transcription Factors; C099252:oxidized low density lipoprotein; D002784:Cholesterol; C027576:4-hydroxy-2-nonenal